46 related articles for article (PubMed ID: 12182050)
21. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
22. [Investigating patients with differentiated thyroid carcinoma and elevated serum thyroglobulin but negative whole-body scan].
Rosário PW; Maia FC; Barroso AL; Purisch S
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):246-52. PubMed ID: 16184253
[TBL] [Abstract][Full Text] [Related]
23. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans.
Clark OH; Hoelting T
Thyroid; 1994; 4(4):501-5. PubMed ID: 7711516
[TBL] [Abstract][Full Text] [Related]
24. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
25. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
26. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning.
Ma C; Kuang A; Xie J; Ma T
J Nucl Med; 2005 Sep; 46(9):1473-80. PubMed ID: 16157530
[TBL] [Abstract][Full Text] [Related]
27. Overview of the management of differentiated thyroid cancer.
Fernandes JK; Day TA; Richardson MS; Sharma AK
Curr Treat Options Oncol; 2005 Jan; 6(1):47-57. PubMed ID: 15610714
[TBL] [Abstract][Full Text] [Related]
28. Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.
Giovanella L; Clark PM; Chiovato L; Duntas L; Elisei R; Feldt-Rasmussen U; Leenhardt L; Luster M; Schalin-Jäntti C; Schott M; Seregni E; Rimmele H; Smit J; Verburg FA
Eur J Endocrinol; 2014 Aug; 171(2):R33-46. PubMed ID: 24743400
[TBL] [Abstract][Full Text] [Related]
29. [Advances in Diagnosis and Treatment of Differentiated Thyroid Cancer in Patients Showing Thyroglobulin Elevative and Iodine Scintigraphy Negative].
Ma N; Li S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):707-11. PubMed ID: 26486005
[TBL] [Abstract][Full Text] [Related]
30. Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients.
Hurley JR
Endocr Pract; 2000; 6(5):401-6. PubMed ID: 11141594
[TBL] [Abstract][Full Text] [Related]
31. Postoperative management of differentiated thyroid cancer.
Cohen EG; Tuttle RM; Kraus DH
Otolaryngol Clin North Am; 2003 Feb; 36(1):129-57. PubMed ID: 12803014
[TBL] [Abstract][Full Text] [Related]
32. Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
McLaughlin CM; Hunter SJ; Bell PM; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2008 Jul; 69(1):169-70. PubMed ID: 18042175
[No Abstract] [Full Text] [Related]
33. Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?
McDougall IR
J Endocrinol Invest; 2001 Mar; 24(3):194-8. PubMed ID: 11314751
[No Abstract] [Full Text] [Related]
34. Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs.
Teunissen JJ; Kwekkeboom DJ; Krenning EP
Trends Endocrinol Metab; 2006; 17(1):19-25. PubMed ID: 16311041
[TBL] [Abstract][Full Text] [Related]
35. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
[TBL] [Abstract][Full Text] [Related]
36. [Poorly differentiated thyroid carcinomas: new therapeutic considerations].
Graf H
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):711-8. PubMed ID: 16444353
[TBL] [Abstract][Full Text] [Related]
37. [Contemporary role of scintigraphy in diagnosis, and evaluation of radioiodine therapy for treatment of thyroid diseases].
Jurgilewicz DH; Rogowski F
Wiad Lek; 2002; 55(1-2):88-99. PubMed ID: 12043321
[TBL] [Abstract][Full Text] [Related]
38. Recurrent and/or metastatic thyroid cancer: therapeutic options.
Karavitaki N; Vlassopoulou V; Tzanela M; Tzavara I; Thalassinos N
Expert Opin Pharmacother; 2002 Jul; 3(7):939-47. PubMed ID: 12083993
[TBL] [Abstract][Full Text] [Related]
39. Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature.
Campennì A; Giovinazzo S; Tuccari G; Fogliani S; Ruggeri RM; Baldari S
Arch Endocrinol Metab; 2015 Aug; 59(4):351-4. PubMed ID: 26331324
[TBL] [Abstract][Full Text] [Related]
40. Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature.
Van Nostrand D; Veytsman I; Kulkarni K; Heimlich L; Burman KD
Thyroid; 2023 Jun; 33(6):674-681. PubMed ID: 36792922
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
